These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19811046)

  • 1. Chronic inflammation in Alzheimer's disease offers therapeutic opportunities.
    McGeer EG; McGeer PL
    Expert Rev Neurother; 2001 Sep; 1(1):53-60. PubMed ID: 19811046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inflammation and Alzheimer's disease].
    de Toledo M
    Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and the degenerative diseases of aging.
    McGeer PL; McGeer EG
    Ann N Y Acad Sci; 2004 Dec; 1035():104-16. PubMed ID: 15681803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
    de Jong D; Jansen RW; Verbeek MM; Kremer HP
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
    Gasparini L; Ongini E; Wilcock D; Morgan D
    Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity, local inflammation, and degenerative disease.
    McGeer PL; McGeer EG
    Sci Aging Knowledge Environ; 2002 Jul; 2002(29):re3. PubMed ID: 14602998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
    McGeer PL; McGeer EG
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S1-6. PubMed ID: 9769023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory processes in Alzheimer's disease.
    McGeer EG; McGeer PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):741-9. PubMed ID: 12921904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of inflammation in Alzheimer's disease.
    Rosenberg PB
    Int Rev Psychiatry; 2005 Dec; 17(6):503-14. PubMed ID: 16401549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of inflammation in Alzheimer's disease.
    Tuppo EE; Arias HR
    Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
    Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
    Gasparini L; Ongini E; Wenk G
    J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.